Contact Us
Atrial Septal Defect Global Market Report 2025
Global Atrial Septal Defect Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Atrial Septal Defect Global Market Report 2025

By Treatment Procedure (Surgical Closure, Transcatheter Closure, Hybrid Procedures, Medication Therapy), By Diagnosis (Chest X-Ray, Electrocardiogram, Cardiac Catheterization, Transesophageal Echocardiography, Pulse Oximetry), By Product Type (Medical Devices, Pharmaceutical Products), By Age Group (Pediatric, Adult), By End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Atrial Septal Defect Market Overview

• Atrial Septal Defect market size has reached to $4.14 billion in 2024

• Expected to grow to $5.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%

• Growth Driver: Growing Prevalence of Congenital Heart Defects (CHD) Drive Atrial Septal Defect Market Expansion

• Market Trend: Advancements In Occluders For Arterial Septal Defect Treatment

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Atrial Septal Defect Market?

An atrial septal defect (ASD) refers to a congenital heart defect characterized by an abnormal opening in the septum, the wall separating the heart's two upper chambers (atria). This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, which can lead to increased blood flow to the lungs and over time cause complications like pulmonary hypertension and heart failure.

The main treatment procedures for arterial septal defect are surgical closure, transcatheter closer, hybrid procedures, and medication therapy. Surgical closure refers to a procedure where an abnormal opening or defect in the body, such as in the heart, is repaired or sealed through surgical intervention. Diagnostic methods encompass chest X-rays, electrocardiograms, cardiac catheterization, transesophageal echocardiography, and pulse oximetry, facilitated by medical devices and pharmaceutical products. These diagnostics serve Pediatric and adult patients across various end-user settings, including hospitals, ambulatory surgical centers, cardiac clinics, and others.

Atrial Septal Defect Market Size and growth rate 2025 to 2029: Graph

What Is The Atrial Septal Defect Market Size 2025 And Growth Rate?

The atrial septal defect market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in number of congenital heart disease cases, increased funding for research and development of ASD treatments, high awareness about congenital heart defects among parents and healthcare providers, higher rates of pediatric surgeries, approval of new ASD closure devices and therapies by regulatory bodies like the FDA, expansion of healthcare facilities.

What Is The Atrial Septal Defect Market Growth Forecast?

The atrial septal defect market size is expected to see strong growth in the next few years. It will grow to $5.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increased use of telemedicine for pre and post-operative care, growth in personalized treatment plans based on genetic and phenotypic data, continued increase in global healthcare spending, particularly in emerging markets, growing elderly population leading to a higher incidence of congenital heart defects being diagnosed later in life international harmonization of medical device regulations improving global market penetration, implementation of national and international health programs targeting early detection and treatment of congenital heart diseases. Major trends in the forecast period include development of new, minimally invasive ASD closure devices, the use of AI and machine learning for improved diagnosis and personalized treatment planning, introduction of biodegradable and bioresorbable materials for device manufacturing, AI-driven tools for real-time monitoring and decision support during ASD procedures, adoption of remote monitoring technologies to track patient recovery and detect complications early.

The forecast of 7.3% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. pediatric cardiology by increasing costs for occluder devices and transesophageal echocardiography equipment imported from Sweden and Germany, potentially prolonging congenital heart defect repairs and raising surgical costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Atrial Septal Defect Market Segmented?

1) By Treatment Procedure: Surgical Closure, Transcatheter Closure, Hybrid Procedures, Medication Therapy

2) By Diagnosis: Chest X-Ray, Electrocardiogram, Cardiac Catheterization, Transesophageal Echocardiography, Pulse Oximetry

3) By Product Type: Medical Devices, Pharmaceutical Products

4) By Age Group: Pediatric, Adult

5) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Other End-Users

Subsegments:

1) By Surgical Closure: Open Heart Surgery (Traditional Surgical Closure), Minimally Invasive Surgical Closure, Patches (Pericardial, Synthetic) For Asd Closure

2) By Transcatheter Closure: Device-Based Closure (Amplatzer Septal Occluder), Transcatheter Plug Closure Techniques, Catheter-Based Asd Repair For Adult And Pediatric Patients

3) By Hybrid Procedures: Combination Of Surgical And Transcatheter Techniques, Minimally Invasive Hybrid Procedures, Hybrid Closure For Complex Or Large Asds

4) By Medication Therapy: Anticoagulant Therapy (To Prevent Stroke), Diuretics (For Managing Symptoms), Antihypertensive Drugs (For Managing Associated Conditions), Off-Label Use Of Other Medications

What Is Driving The Atrial Septal Defect Market? Growing Prevalence of Congenital Heart Defects (CHD) Drive Atrial Septal Defect Market Expansion

The prevalence of congenital heart defects (CHD) is expected to propel the growth of the atrial septal defect market going forward. Congenital heart defects refer to structural abnormalities in the heart present at birth. The increasing prevalence of congenital heart defects refers to the growing number of individuals diagnosed with structural heart abnormalities present from birth. Atrial septal defect treatment helps manage congenital heart defects by correcting abnormal blood flow between the heart's chambers, improving overall heart function, and reducing associated complications. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based national agency, in Australia, approximately 65,000 children and adults are living with congenital heart disease. In the 2020–21 period, there were about 5,900 hospitalizations where congenital heart disease was the primary diagnosis, accounting for 79 deaths in infants under one year old, representing 7.8% of all infant deaths. Therefore, the prevalence of congenital heart defects will drive the atrial septal defect industry.

Who Are The Major Players In The Global Atrial Septal Defect Market?

Major companies operating in the atrial septal defect market are Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC

What Are The Key Trends Of The Global Atrial Septal Defect Market? Advancements In Occluders For Arterial Septal Defect Treatment

Major companies operating in the arterial septal defect market are developing advanced devices and seeking approval to increase their availability and uses. Device approval refers to obtaining official authorization or certification for a device, typically from a regulatory body or relevant authority, before IT can be legally manufactured, sold, or used in a specific market or for a particular purpose. For instance, in March 2024, Occlutech GmbH, a Sweden-based specialist provider of minimally invasive cardiac devices, announced that the United States Food and Drug Administration (FDA) had approved the Occlutech ASD Occluder and Occlutech Pistol Pusher for treating atrial septal defects (ASD). This approval marks a significant milestone for the company, which has been working to advance healthcare globally. The Occlutech ASD Occluder is designed to be a lifelong solution for patients with echocardiography-confirmed defects. It is a self-expanding nitinol device that includes two flexible discs attached to both sides of the patient's atrial septum using the Occlutech Pistol Pusher. With this approval, Occlutech will begin commercialization in the US through an exclusive partnership with B. Braun Interventional Systems.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Atrial Septal Defect Market? Expansion Of Boston Scientific's Product Portfolio Through Acquisition Of Baylis Medical

In February 2022, Boston Scientific Corporation, a US-based medical products company, acquired Baylis Medical Company Inc. for $1.75 billion. The acquisition expands Boston Scientific's electrophysiology and structural heart product portfolios to include Baylis Medical's transseptal platforms and guidewires, sheaths, and dilators for left heart access. Baylis Medical Company Inc. is a Canada-based medical company that manufactures the VersaCross RF Wire, designed to create atrial septal defects in the heart.

What Is The Regional Outlook For The Global Atrial Septal Defect Market?

North America was the largest region in the atrial septal defect market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Atrial Septal Defect Market?

The atrial septal defect (ASD) market consists of revenues earned by entities by provide services such as diagnosis and monitoring, medication management, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial septal defect (ASD) market also includes sales of septal occluder devices, cardiac MRI systems, and anticoagulant medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Atrial Septal Defect Industry?

The atrial septal defect market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the atrial septal defect industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Atrial Septal Defect Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.46 billion
Revenue Forecast In 2034 $5.91 billion
Growth Rate CAGR of 7.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Treatment Procedure: Surgical Closure, Transcatheter Closure, Hybrid Procedures, Medication Therapy
2) By Diagnosis: Chest X-Ray, Electrocardiogram, Cardiac Catheterization, Transesophageal Echocardiography, Pulse Oximetry
3) By Product Type: Medical Devices, Pharmaceutical Products
4) By Age Group: Pediatric, Adult
5) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Other End-Users Subsegments: 1) By Surgical Closure: Open Heart Surgery (Traditional Surgical Closure), Minimally Invasive Surgical Closure, Patches (Pericardial, Synthetic) For Asd Closure
2) By Transcatheter Closure: Device-Based Closure (Amplatzer Septal Occluder), Transcatheter Plug Closure Techniques, Catheter-Based Asd Repair For Adult And Pediatric Patients
3) By Hybrid Procedures: Combination Of Surgical And Transcatheter Techniques, Minimally Invasive Hybrid Procedures, Hybrid Closure For Complex Or Large Asds
4) By Medication Therapy: Anticoagulant Therapy (To Prevent Stroke), Diuretics (For Managing Symptoms), Antihypertensive Drugs (For Managing Associated Conditions), Off-Label Use Of Other Medications
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Atrial Septal Defect Market Characteristics

3. Atrial Septal Defect Market Trends And Strategies

4. Atrial Septal Defect Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Atrial Septal Defect Growth Analysis And Strategic Analysis Framework

5.1. Global Atrial Septal Defect PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Atrial Septal Defect Market Growth Rate Analysis

5.4. Global Atrial Septal Defect Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Atrial Septal Defect Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Atrial Septal Defect Total Addressable Market (TAM)

6. Atrial Septal Defect Market Segmentation

6.1. Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgical Closure

Transcatheter Closure

Hybrid Procedures

Medication Therapy

6.2. Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chest X-Ray

Electrocardiogram

Cardiac Catheterization

Transesophageal Echocardiography

Pulse Oximetry

6.3. Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medical Devices

Pharmaceutical Products

6.4. Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatric

Adult

6.5. Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ambulatory Surgical Centers

Cardiac Clinics

Other End-Users

6.6. Global Atrial Septal Defect Market, Sub-Segmentation Of Surgical Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Open Heart Surgery (Traditional Surgical Closure)

Minimally Invasive Surgical Closure

Patches (Pericardial, Synthetic) For Asd Closure

6.7. Global Atrial Septal Defect Market, Sub-Segmentation Of Transcatheter Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Device-Based Closure (Amplatzer Septal Occluder)

Transcatheter Plug Closure Techniques

Catheter-Based Asd Repair For Adult And Pediatric Patients

6.8. Global Atrial Septal Defect Market, Sub-Segmentation Of Hybrid Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination Of Surgical And Transcatheter Techniques

Minimally Invasive Hybrid Procedures

Hybrid Closure For Complex Or Large Asds

6.9. Global Atrial Septal Defect Market, Sub-Segmentation Of Medication Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anticoagulant Therapy (To Prevent Stroke)

Diuretics (For Managing Symptoms)

Antihypertensive Drugs (For Managing Associated Conditions)

Off-Label Use Of Other Medications

7. Atrial Septal Defect Market Regional And Country Analysis

7.1. Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Atrial Septal Defect Market

8.1. Asia-Pacific Atrial Septal Defect Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Atrial Septal Defect Market

9.1. China Atrial Septal Defect Market Overview

9.2. China Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Atrial Septal Defect Market

10.1. India Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Atrial Septal Defect Market

11.1. Japan Atrial Septal Defect Market Overview

11.2. Japan Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Atrial Septal Defect Market

12.1. Australia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Atrial Septal Defect Market

13.1. Indonesia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Atrial Septal Defect Market

14.1. South Korea Atrial Septal Defect Market Overview

14.2. South Korea Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Atrial Septal Defect Market

15.1. Western Europe Atrial Septal Defect Market Overview

15.2. Western Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Atrial Septal Defect Market

16.1. UK Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Atrial Septal Defect Market

17.1. Germany Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Atrial Septal Defect Market

18.1. France Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Atrial Septal Defect Market

19.1. Italy Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Atrial Septal Defect Market

20.1. Spain Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Atrial Septal Defect Market

21.1. Eastern Europe Atrial Septal Defect Market Overview

21.2. Eastern Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Atrial Septal Defect Market

22.1. Russia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Atrial Septal Defect Market

23.1. North America Atrial Septal Defect Market Overview

23.2. North America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Atrial Septal Defect Market

24.1. USA Atrial Septal Defect Market Overview

24.2. USA Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Atrial Septal Defect Market

25.1. Canada Atrial Septal Defect Market Overview

25.2. Canada Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Atrial Septal Defect Market

26.1. South America Atrial Septal Defect Market Overview

26.2. South America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Atrial Septal Defect Market

27.1. Brazil Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Atrial Septal Defect Market

28.1. Middle East Atrial Septal Defect Market Overview

28.2. Middle East Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Atrial Septal Defect Market

29.1. Africa Atrial Septal Defect Market Overview

29.2. Africa Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Atrial Septal Defect Market Competitive Landscape And Company Profiles

30.1. Atrial Septal Defect Market Competitive Landscape

30.2. Atrial Septal Defect Market Company Profiles

30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Atrial Septal Defect Market Other Major And Innovative Companies

31.1. Edwards Lifesciences Corporation

31.2. W. L. Gore & Associates Inc.

31.3. St. Jude Medical LLC

31.4. Cook Medical

31.5. Lepu Medical Technology Co. Ltd.

31.6. MicroPort Scientific Corporation

31.7. Lifetech Scientific Corporation

31.8. Venus Medtech Hangzhou Inc

31.9. Occlutech Holding AG

31.10. Coherex Medical

31.11. Osypka AG

31.12. Arjo AB

31.13. Heart Medical Europe BV

31.14. AtriCure Inc.

31.15. Asklepion Pharmaceuticals LLC

32. Global Atrial Septal Defect Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Atrial Septal Defect Market

34. Recent Developments In The Atrial Septal Defect Market

35. Atrial Septal Defect Market High Potential Countries, Segments and Strategies

35.1 Atrial Septal Defect Market In 2029 - Countries Offering Most New Opportunities

35.2 Atrial Septal Defect Market In 2029 - Segments Offering Most New Opportunities

35.3 Atrial Septal Defect Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Atrial Septal Defect Market, Sub-Segmentation Of Surgical Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Atrial Septal Defect Market, Sub-Segmentation Of Transcatheter Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Atrial Septal Defect Market, Sub-Segmentation Of Hybrid Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Atrial Septal Defect Market, Sub-Segmentation Of Medication Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Abbott Laboratories Financial Performance
  • Table 81: Medtronic plc Financial Performance
  • Table 82: Siemens Healthineers Financial Performance
  • Table 83: Boston Scientific Corporation Financial Performance
  • Table 84: Philips Healthcare Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Atrial Septal Defect Market, Sub-Segmentation Of Surgical Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Atrial Septal Defect Market, Sub-Segmentation Of Transcatheter Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Atrial Septal Defect Market, Sub-Segmentation Of Hybrid Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Atrial Septal Defect Market, Sub-Segmentation Of Medication Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Abbott Laboratories Financial Performance
  • Figure 81: Medtronic plc Financial Performance
  • Figure 82: Siemens Healthineers Financial Performance
  • Figure 83: Boston Scientific Corporation Financial Performance
  • Figure 84: Philips Healthcare Financial Performance

Frequently Asked Questions

An atrial septal defect (ASD) refers to a congenital heart defect characterized by an abnormal opening in the septum, the wall separating the heart's two upper chambers (atria). This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, which can lead to increased blood flow to the lungs and over time cause complications like pulmonary hypertension and heart failure. For further insights on this market, request a sample here

The market major growth driver - Growing Prevalence of Congenital Heart Defects (CHD) Drive Atrial Septal Defect Market Expansion. For further insights on this market, request a sample here

The atrial septal defect market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in number of congenital heart disease cases, increased funding for research and development of ASD treatments, high awareness about congenital heart defects among parents and healthcare providers, higher rates of pediatric surgeries, approval of new ASD closure devices and therapies by regulatory bodies like the FDA, expansion of healthcare facilities. The atrial septal defect market size is expected to see strong growth in the next few years. It will grow to " $5.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increased use of telemedicine for pre and post-operative care, growth in personalized treatment plans based on genetic and phenotypic data, continued increase in global healthcare spending, particularly in emerging markets, growing elderly population leading to a higher incidence of congenital heart defects being diagnosed later in life international harmonization of medical device regulations improving global market penetration, implementation of national and international health programs targeting early detection and treatment of congenital heart diseases. Major trends in the forecast period include development of new, minimally invasive ASD closure devices, the use of AI and machine learning for improved diagnosis and personalized treatment planning, introduction of biodegradable and bioresorbable materials for device manufacturing, AI-driven tools for real-time monitoring and decision support during ASD procedures, adoption of remote monitoring technologies to track patient recovery and detect complications early. For further insights on this market, request a sample here

The atrial septal defectmarket covered in this report is segmented –
1) By Treatment Procedure: Surgical Closure; Transcatheter Closure; Hybrid Procedures; Medication Therapy
2) By Diagnosis: Chest X-Ray; Electrocardiogram; Cardiac Catheterization; Transesophageal Echocardiography; Pulse Oximetry
3) By Product Type: Medical Devices; Pharmaceutical Products
4) By Age Group: Pediatric; Adult
5) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Other End-Users Subsegments:
1) By Surgical Closure: Open Heart Surgery (Traditional Surgical Closure); Minimally Invasive Surgical Closure; Patches (Pericardial, Synthetic) For Asd Closure
2) By Transcatheter Closure: Device-Based Closure (Amplatzer Septal Occluder); Transcatheter Plug Closure Techniques; Catheter-Based Asd Repair For Adult And Pediatric Patients
3) By Hybrid Procedures: Combination Of Surgical And Transcatheter Techniques; Minimally Invasive Hybrid Procedures; Hybrid Closure For Complex Or Large Asds
4) By Medication Therapy: Anticoagulant Therapy (To Prevent Stroke); Diuretics (For Managing Symptoms); Antihypertensive Drugs (For Managing Associated Conditions); Off-Label Use Of Other Medications For further insights on this market,
request a sample here

North America was the largest region in the atrial septal defect market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial septal defect market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the atrial septal defect market are Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC. For further insights on this market, request a sample here.

Major trends in this market include Advancements In Occluders For Arterial Septal Defect Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon